Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS ONE ; Band 7 (2012), Heft 10. - S.e48042:1-e48042:6. - ISSN 1932-6203
- Ereignis
-
Veröffentlichung
- (wo)
-
Kiel
- (wer)
-
Universitätsbibliothek Kiel
- (wann)
-
2012
- Urheber
-
Maetzler, Walter
Tian, Youyong
Baur, Stephanie Maria
Gauger, Tina
Odoj, Bartholomäus
Schmid, Benjamin
Schulte, Claudia
Deuschle, Christian
Heck, Susanna
Apel, Anja
Melms, Arthur
Gasser, Thomas
Berg, Daniela
- URN
-
urn:nbn:de:gbv:8-publ-22915
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maetzler, Walter
- Tian, Youyong
- Baur, Stephanie Maria
- Gauger, Tina
- Odoj, Bartholomäus
- Schmid, Benjamin
- Schulte, Claudia
- Deuschle, Christian
- Heck, Susanna
- Apel, Anja
- Melms, Arthur
- Gasser, Thomas
- Berg, Daniela
- Universitätsbibliothek Kiel
Entstanden
- 2012
Ähnliche Objekte (12)
Biomarkers in Alzheimer's disease and lewy body disorders with dementia.
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies
Dementia and geriatric cognitive disorders, [...]. Extra
Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies
The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies
Dementia-associated changes of immune cell composition within the cerebrospinal fluid
Automatic Detection of Dementia and related Affective Disorders through Processing of Speech and Language
Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables
Antibody indices of infectious pathogens from serum and cerebrospinal fluid in patients with schizophrenia spectrum disorders
Neurotoxicity and aggregation of β-synuclein and its P123H and V70M mutants associated with dementia with Lewy bodies
Biomarkers in Alzheimer's disease and lewy body disorders with dementia.
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies
Dementia and geriatric cognitive disorders, [...]. Extra
Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies
The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies
Dementia-associated changes of immune cell composition within the cerebrospinal fluid
Automatic Detection of Dementia and related Affective Disorders through Processing of Speech and Language
Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables
Antibody indices of infectious pathogens from serum and cerebrospinal fluid in patients with schizophrenia spectrum disorders
Neurotoxicity and aggregation of β-synuclein and its P123H and V70M mutants associated with dementia with Lewy bodies
Biomarkers in Alzheimer's disease and lewy body disorders with dementia.
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies
Dementia and geriatric cognitive disorders, [...]. Extra
Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies
The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies
Dementia-associated changes of immune cell composition within the cerebrospinal fluid
Automatic Detection of Dementia and related Affective Disorders through Processing of Speech and Language
Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables
Antibody indices of infectious pathogens from serum and cerebrospinal fluid in patients with schizophrenia spectrum disorders